BOSTON, Mass. -- Five million Americans are suffering with Alzheimer's Disease and that number is expected to grow. There's been a huge push to develop a drug tat can slow down the disease, and now researchers near Boston believe they've found an answer.
Alzheimer's is affecting Walter Hartel's tempo. The 67-year-old was diagnosed four years ago with the disease, which limits his ability to get around alone and with his wife.
"We traveled all around the world and I can't
imagine doing that now," said Walter's wife, Karen Barry. "Our world has become very small."
Now researchers in Boston are hopeful they can help patients like Walter with a new drug, called Dimebon.
Dr. Michael Biber, Neurocare Center for Research said, "We're doing just as well, the average patient, in terms of their thinking, 18 months after they started the trial. in other words, there was no progression during that time."
Dimebon was developed in Russia in the 1980s to treat stuff noses. Doctors there soon discovered it had an effect on memory, which lead to more testing.
The initial studies were so promising it is now undergoing a last round of trials in Boston.
Dimebon is also easier for patients to take than other drugs currently being tested, most of which involve injections.
"It's a pill, that people take. and that's very unique amongst
the drugs that are now the leading contenders for treatment for Alzheimer's disease," said Dr. Biber.
Dimebon still faces the FDA when testing is finally finished, but with positive results so far, doctors and drug companies are confident it will be approved and patients like Walter will benefit.
Mallika Marshal, CBS News Boston.
The Neurocare Center for Research is still looking for participants for their study on Dimebon.
To qualify, people must be between age 55 and 85 and have mild to moderate Alzheimer's. For more information click on the link below.
Athletes who weren't diagnosed with concussions still showed thinking deficits after a season of hits
Study finds no evidence to support that belief
The European Food Safety Authority says the artificial sweetener aspartame is safe at the levels currently used in food and drinks.
Early studies found small improvement with combo therapy for HER2-positive disease
However, review didn't include women in their 40s, so debate may not end
SAN ANTONIO (AP) — Tens of thousands of women each year might be able to skip at least some of the grueling treatments for breast cancer — which can include surgery, heavy chemo and radiation — without greatly harming their odds of survival, new research suggests.
By David Lawder and Thomas Ferraro WASHINGTON (Reuters) - Republicans in the U.S. House of Representatives on Wednesday were falling in line behind a bipartisan two-year budget deal, indicating that the normally rambunctious group of lawmakers is not spoiling for a year-end fiscal fight. Despite conservative groups' denunciation of the plan and public opposition from some members associated with the conservative Tea Party movement, the Republican-controlled House was planning to vote on Thursday to pass the deal, Representative Kevin McCarthy, the third-ranking Republican told Reuters. A key House panel, on a 9-3 vote, cleared the legislation for debate and votes in the full House. The Republican-controlled Rules Committee refused to allow Democrats to offer an amendment to extend federal unemployment benefits that expire later this month.
Chinese authorities have told pilots who fly to Beijing they must be qualified to land their aircraft in the low visibility bought about by smog, state media said on Thursday, as the government tries to reduce flight delays due to pollution. Beginning January 1, pilots flying from the country's 10 busiest airports into the Chinese capital must be qualified to use an instrument landing system on days when smog reduces visibility to around 400 meters (1,315 feet), the official China Daily said, citing China's civil aviation regulator. Despite investing billions of dollars in new airports and advanced Western-built aircraft, China suffers a chronic problem with flight delays, partly because of the country's often wildly-fluctuating weather and partly because the military tightly controls most of China's airspace.